Takeda Pharmaceutical Co., Ltd. (TAK)
Takeda Pharmaceutical Market Cap: 45.40B for Dec. 10, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Pfizer Inc. | 146.55B |
| Bristol Myers Squibb Co. | 104.24B |
| Johnson & Johnson | 497.54B |
| Novartis AG | 251.71B |
| Sanofi | 117.75B |
Market Cap Related Metrics
| PE Ratio | 182.42 |
| PS Ratio | 1.547 |
| Price to Book Value | 0.9403 |
| Price to Free Cash Flow | 8.316 |
| Price | 14.38 |
| Earnings Yield | 0.55% |
| Operating PE Ratio | 13.99 |
| Normalized PE Ratio | 77.04 |